TJX(US:TJX)2025-11-19 14:12Financial Performance - Q3 FY26 net sales reached $15.1 billion, a 7% increase compared to Q3 FY25[1] - Consolidated comparable sales for Q3 FY26 increased by 5%, exceeding the company's plan[4] - Q3 FY26 diluted earnings per share were $1.28, up 12% from $1.14 in Q3 FY25[1] - For the first nine months of FY26, net sales totaled $42.6 billion, a 7% increase year-over-year[2] - Net sales for the thirteen weeks ended November 1, 2025, were $15,117 million, an increase of 7.5% compared to $14,063 million for the same period in 2024[32] - Net income for the thirty-nine weeks ended November 1, 2025, was $3,721 million, up from $3,466 million for the same period in 2024, representing an increase of 7.3%[32] - Diluted earnings per share for the thirteen weeks ended November 1, 2025, were $1.28, compared to $1.14 for the same period in 2024, reflecting a growth of 12.3%[32] Shareholder Returns - The company returned $1.1 billion to shareholders in Q3 FY26 through share repurchases and dividends[11] - The company returned $1.1 billion to shareholders during the third quarter, including $594 million for repurchasing 4.2 million shares and $472 million in dividends[40] - The company plans to repurchase approximately $2.5 billion of its stock during the fiscal year ending January 31, 2026[13] - The company has approximately $1.9 billion available for stock repurchase as of November 1, 2025, under its new stock repurchase program[40] Inventory and Assets - Total inventories as of November 1, 2025, were $9.4 billion, an increase of 12% from the previous year[10] - Merchandise inventories increased to $9,353 million as of November 1, 2025, from $8,371 million as of November 2, 2024, marking a rise of 11.7%[34] - Total assets as of November 1, 2025, were $35,188 million, an increase from $32,436 million as of November 2, 2024, indicating a growth of 8.6%[34] Profitability - The pretax profit margin for Q3 FY26 was 12.7%, 0.4 percentage points higher than the previous year[7] - Segment profit for Marmaxx in the United States was $1,350 million for the thirteen weeks ended November 1, 2025, compared to $1,207 million for the same period in 2024, a growth of 11.8%[39] Future Outlook - For Q4 FY26, the company expects consolidated comparable sales to increase by 2% to 3%[15] - The full year FY26 guidance includes a projected 4% increase in consolidated comparable sales and diluted EPS in the range of $4.63 to $4.66[16] - The company anticipates continued growth in operating and financial performance, despite potential risks including competition and economic conditions[28] Cash Position - Cash and cash equivalents at the end of the period were $4,640 million, down from $4,718 million at the end of the same period last year, a decrease of 1.7%[36]